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Initial stages of implantation involve bi-directional molecular crosstalk between the blastocyst 
and endometrium. This study investigated an association between infertility etiologies, 
specifically advanced maternal age (AMA) and endometriosis, on the embryo-endometrial 
molecular dialogue prior to implantation. Co-culture experiments were performed with 
endometrial epithelial cells (EEC) and cryopreserved day 5 blastocysts (n = 41 羽 Grade 3BB) 
donated from patients presenting with AMA or endometriosis, compared to fertile donor 
oocyte controls. Extracellular vesicles isolated from co-culture supernatant were analyzed for 
miRNA expression and revealed significant alterations correlating to AMA or endometriosis. 
Specifically, AMA resulted in 16 miRNAs with increased expression (P 烏 0.05) and strong 
evidence for negative regulation toward 206 target genes. VEGFA, a known activator of cell 
adhesion, displayed decreased expression (P 烏 0.05), validating negative regulation by 4 of 
these increased miRNAs: miR-126; 150; 29a; 29b (P 烏 0.05). In endometriosis patients, a total 
of 10 significantly altered miRNAs displayed increased expression compared to controls (miR-
7b; 9; 24; 34b; 106a; 191; 200b; 200c; 342-3p; 484) (P 烏 0.05), targeting 1014 strong evidence-
based genes. Three target genes of miR-106a (CDKN1A, E2F1 and RUNX1) were independently 
validated. Functional annotation analysis of miRNA-target genes revealed enriched pathways 
for both infertility etiologies, including disrupted cell cycle regulation and proliferation (P 烏 
0.05). These extracellular vesicle-bound secreted miRNAs are key transcriptional regulators in 
embryo-endometrial dialogue and may be prospective biomarkers of implantation success. One 
of the limitations of this study is that it was a stimulated, in vitro model and therefore may not 




The World Health Organization estimates that 10% of couples worldwide will struggle with 
infertility. Although a small number of these reproductive-age couples may succeed using 
conventional methods over many months and possibly years, most will require the use of 
assisted reproductive technologies (ARTs) and often in vitro fertilization (IVF) to establish a 
pregnancy (Thoma et al. 2013). Although considered relatively successful, 70% of IVF cycles will 
not result in a live birth (Weimar et al. 2013).  
An intricate, bi-directional molecular dialogue between embryo and endometrium during the 
window of implantation, approximately 6 ?12 days post ovulation, is crucial for success (Wilcox 
et al. 1999). Without a precise interchange between the two, implantation will ultimately fail. 
Key genes involved with cell cycle regulation, as well as ion-binding and signal-transporting 
proteins, have been identified as contributors to the molecular dialogue between the embryo 
and a receptive endometrium by sampling the uterine microenvironment (Hannan et al. 2012, 
Ruiz- Alonso et al. 2012). MicroRNAs (miRNAs) also play an important role during the window of 
implantation and are expressed by both the implanting embryo and the receptive endometrium 
(Blakaj & Lin 2008, Laurent 2008). Altered expression of miRNAs (including miR- 30b, miR-30d 
and miR-494) have been shown to regulate endometrial receptivity (Altmae et al. 2013).  
An in vitro co-culture system can provide valuable insight into the initial bi-directional 
dialogue (Simon et al. 1998). In vitro studies utilizing an embryo/ endometrial co-culture system 
have observed key components of the molecular crosstalk between the embryo and 
endometrial epithelial cells (EEC). However, limited information regarding this interaction is 
known (Barmat et al. 1999, Simon et al. 1999, Rubio et al. 2000).  
Our unique study utilized a human uterine luminal endometrial epithelial cell and human 
blastocyst co-culture system to investigate the molecular dialogue at the time of adhesion, in 
association with two major causes of female factor infertility (endometriosis and advanced 
maternal age). Advanced maternal age (AMA) is associated with a substantial linear decline in 
reproductive potential and is the major cause of female infertility (Rosenwaks et al. 1995). 
There are many factors contributing to the significant decrease in live births as women 
approach their 5th decade, including diminishing ovarian reserve (Zhang 2015), and the 
increase in oocyte chromosomal aneuploidy (Harton et al. 2013). Aneuploidy screening in IVF 
cycles has allowed for the transfer of euploid blastocysts, resulting in higher implantation rates, 
independent of maternal age (Schoolcraft et al. 2011). However, there are other variables 
beyond the oocyte/embryo chromosome constitution that impact the ability of a euploid 
blastocyst to successfully implant. Traditionally, AMA patients are shown to have a longer 
infertility duration and diminished ovarian reserve and require a higher dose of gonadotropins 
in controlled ovarian hyperstimulation, all resulting in poorer oocyte quality (Ocal et al. 2012).  
Another pathological cause of infertility, widely diagnosed and treated within the field of 
reproductive medicine, is endometriosis. Endometriosis is a disease which causes tissue 
normally found within the uterus, to migrate and grow outside of it (Buck Louis et al. 2011). 
dŚŝƐ ĚĞďŝůŝƚĂƚŝŶŐ ĚŝƐĞĂƐĞ ŝƐ ŽĨƚĞŶ ƉĂŝŶĨƵů ? ŝŵƉĂĐƚŝŶŐĂ ǁŽŵĂŶ ?Ɛ ƋƵĂůŝƚǇ ŽĨ ůŝĨĞ ? ĂŶĚ ŐƌĞĂƚůǇ
reduces the chances of conception. It is estimated that nearly half of all women with this 
diagnosis will have difficulty achieving a pregnancy (Practice Committee of the American 
Society for Reproductive Medicine 2006, Ozkan et al. 2008). The causes of endometriosis 
remain unclear; however a genetic predisposition is suspected as a common risk factor, 
including a family history of the condition (Wenzl et al. 2003). Several pathways have also been 
identified within patients diagnosed with endometriosis which may contribute to the poor 
oocyte quality associated with the disease (Shebl et al. 2017). Within infertile populations, it is 
estimated that the prevalence of patients diagnosed with endometriosis is approximately 
26.13% in women undergoing laparoscopy (Garcia- Velasco & Quea 2005, Rizk et al. 2015).  
The aim of this study is to investigate these different primary infertility etiologies within a 
controlled co-culture system, to elucidate differences within the secretome. We found 
significant differences in the miRNA content within the extracellular vesicles of the supernatant, 
as well as differences in gene expression within the co-cultured endometrial cells and 
blastocysts which may impact endometrial function during the window of implantation.  
Materials and methods  
Embryos  
Surplus, cryopreserved, hatching, transfer-grade blastocysts as identified by the Gardner 
& Schoolcraft grading system (Gardner & Schoolcraft 1999) as A?Grade 3BB on day 5 of 
embryonic development (n = 41) were donated with patient consent and IRB approval. 
Blastocysts were derived from IVF cycles: young fertile oocyte donor controls (fertile control 
group) with no history of female or male factor infertility, based on WHO guidelines (maternal 
age A?32 years old, BMI <29, non-smoker, non-drug user, with normal ovarian reserve and 
regular menstrual cycles, n = 15), infertile women of AMA group without pre-implantation 
genetic diagnosis (A?39 years or older, with no other infertility diagnosis, n = 14), and younger 
female patients diagnosed with endometriosis as the only cause of infertility (mean maternal 
age of 34.3, with 11 of the 12 patients A?33 years old, n = 12). Subjects underwent an ovarian 
stimulation protocol based on clinical discretion which included gonadotropin-releasing 
hormone (GnRH) agonist down-regulation, microdose GnRH agonist flare or GnRH antagonist 
with Menopur (Ferring Pharmaceuticals, Saint-Prex, Switzerland) or Bravelle (Ferring 
Pharmaceuticals) with or without clomiphene citrate. Final oocyte maturation trigger was 
induced when the lead follicle reached 20 mm mean diameter using an intramuscular injection 
of hCG, a subcutaneous injection of leuprolide acetate, or a combination of both, based on 
clinical judgment. Routine oocyte retrieval was performed transvaginally under ultrasound 
guidance 35 h post trigger. Patients within the endometriosis group were asymptomatic at the 
time of their oocyte retrieval and biopsy. Patients were excluded from the study if they had any 
other infertility comorbidities including polycystic ovary syndrome and depleted ovarian 
reserve. Embryos were vitrified and warmed according to routine laboratory procedures 
described previously (Kuwayama et al. 2005). Total time spent frozen varied, with an average 
time of approximately 4 years.  
Endometrial biopsies  
Endometrial biopsies were collected from either young, fertile oocyte donors (fertile 
control group, n = 7) or from patients diagnosed with endometriosis who were currently 
asymptomatic at the time of their oocyte retrieval (n = 2). Subjects were stimulated as 
described earlier. Endometrial biopsies measured 1.5 ?3.0 cm in length and approximately 0.5 
cm in diameter. For every endometrial biopsy collected, tissue was minced into <1 mm sections 
and incubated at 4°C overnight in a 0.1% collagenase solution (Sigma-Aldrich). The primary 
epithelial endometrial cells (EEC) were isolated by vigorously vortexing and rinsing the cell 
milieu in 10 mL of room temperature DMEM (Sigma-Aldrich), prior to resting the cells for 5 ?10 
min as they settled into distinct layers of EEC and stromal cells. The supernatant containing 
stromal cells was then removed and the process was repeated three times until no further 
ƐƚƌŽŵĂů ĐĞůůƐ ƌĞŵĂŝŶĞĚ ?  ? ? ? ʅ> ŽĨ ƚŚĞ  ?DD ǁĂƐ ƚŚĞŶ ĂĚĚĞĚ ƚŽ 6 wells of a Falcon 
Multiwell 24-well Tissue Culture Plate (Corning Incorporated) (Mercader et al. 2003). Cells were 
cultured in a media composed of 75% Dulbecco Modified Eagle Medium (Sigma) and 25% 
MCDB-  ? ? ? ?^ŝŐŵĂ ?ĐŽŶƚĂŝŶŝŶŐĂŶƚŝďŝŽƚŝĐƐ ? ?ʅŐ ?ŵ>ŝŶƐƵůin (Sigma) and supplemented with 10% 
exosome-depleted fetal bovine serum (System Biosciences, Palo Alto, CA, USA) and observed 
daily to monitor the development of an EEC monolayer. The monolayer reached acceptable 
levels of well coverage at >65% after 4 ?6 days. The growth medium was then replaced with a 
serum-free medium for embryo development and supplemented with 4% recombinant human 
serum albumin (Vitrolife, Englewood, CO, USA). For each endometrial biopsy processed, 4 ?6 
wells received an individual thawed blastocyst which was co-cultured for 48 h at 5% O2 and 6% 
CO2 at 37°C based on current laboratory practices for human blastocyst culture (Kovacic 2012).  
Co-culture collection  
Blastocysts were co-cultured together for 48 h prior to collection. AMA or fertile control 
donor blastocysts were co-cultured with fertile control donor endometrial tissue. Additionally, 
the endometriosis subjects were divided into three groups: fertile control donor blastocysts co-
cultured with fertile control donor endometrium (CD), fertile control donor blastocysts co-
cultured with endometrial cells from patients diagnosed with endometriosis (ED) and 
blastocysts and endometrial cells that were both obtained from patients diagnosed with 
endometriosis (EE). Adhesion by the blastocyst to the endometrial monolayer was observed 
twice in the AMA group, twice in the fertile control group and once in both of the 
endometriosis groups. Adhered blastocysts were gently scraped off the monolayer prior to 
collection. Following co-culture, blastocysts were graded and rinsed in 10% phosphate buffered 
saline-bovine serum albumin (PBS-^ ?ďĞĨŽƌĞůǇƐŝƐŝŶ ? ?ʅ>ŽĨĞǆƚƌĂĐƚŝŽŶďƵĨĨĞƌ ?WŝĐŽWƵƌĞZE
Isolation Kit, Thermo Fisher Scientific). Co-ĐƵůƚƵƌĞƐƵƉĞƌŶĂƚĂŶƚǁĂƐĐŽůůĞĐƚĞĚ ? ? ? ?ʅ> ?ĂŶĚƐŶĂƉ-
frozen in liquid nitrogen. The monolayer was visually measured for 100% confluence, then 
rinsed with DPBS (Thermo Fisher) and incubated at 37°C with 1× diluted TrypLESelect (10×) 
(Thermo Fisher) until cells lifted from the bottom of the plate (5 ?15 min). Each well of EEC were 
ĐŽůůĞĐƚĞĚŝŶĚŝǀŝĚƵĂůůǇ ?dŚĞƉĞůůĞƚĞĚǁĞƌĞůǇƐĞĚǁŝƚŚ ? ?ʅ>ǆƚƌĂĐƚŝŽŶƵĨĨĞƌ ?WŝĐŽWƵƌĞZE
Isolation Kit, Thermo Fisher) and snap-frozen with liquid nitrogen. All samples were stored at 
AL80°C until further analysis (Fig. 1 ). 
 Figure 1 Experimental design for embryo co-culture with cultured endometrial cells. 
 
Supernatant extracellular vesicle miRNA analysis  
Extracellular vesicles were isolated using Total Exosome Isolation Reagent (from cell 
ĐƵůƚƵƌĞŵĞĚŝĂ ?  ?dŚĞƌŵŽ&ŝƐŚĞƌ ? ?  ? ? ?ʅ>ŽĨƐƵƉĞƌŶĂƚĂŶƚǁ ƐĐŽŵďŝŶĞĚǁŝƚŚ  ? ? ?ʅ>ŽĨ ƌĞĂŐĞŶƚ
and vortex-mixed prior to an overnight incubation at 4°C. Samples were centrifuged under 
refrigerated conditions for 1 h, then the supernatant was aspirated and discarded. The resulting 
ƉĞůůĞƚǁĂƐůǇƐĞĚŝŶ ? ?ʅL of lysis solution containing DNase (Taqman MicroRNA Cells-to-CT Kit, 
Thermo Fisher) and incubated at room temperature for 8 min. Lysed miRNA was reverse-
transcribed using the Taqman MicroRNA Reverse Transcription Kit with MegaPlex RT Human 
Primer Pool A  ?dŚĞƌŵŽ&ŝƐŚĞƌ ?ŝŶĂĨŝŶĂůǀŽůƵŵĞŽĨ  ? ? ?ʅ>ƵŶĚĞƌƚŚĞĨŽůůŽǁŝŶŐƚŚĞƌŵĂůĐǇĐůŝŶŐ
conditions: 40 cycles at 16°C for 2 min, 42°C for 1 min and 50°C for 1 s followed by a hold for 5 
min at 85°C. cDNA was pre-amplified using the Taqman PreAmp Mastermix with MegaPlex 
WƌĞŵƉ,ƵŵĂŶWƌŝŵĞƌWŽŽů ?dŚĞƌŵŽ&ŝƐŚĞƌ ? ? ? ? ?ʅ>ŽĨƚŚĞĚŝůƵƚĞĚƉƌĞ-amplified product was 
added to each well of the Taqman Human MicroRNA Array Card A and was then run on the 
7900HT Fast Real-Time PCR System (Thermo Fisher) under the following thermal cycling 
conditions: 50°C for 2 min, 94.5°C for 10 min and 40 cycles at 97°C for 30 s and 59.7°C for 1 min. 
Data were analyzed using the RQ Manager 1.2.1 (Thermo Fisher), and statistical analysis was 
performed using REST 2009 software (Qiagen). miRNAs that displayed significantly altered 
expression profiles were further investigated for target gene analysis using miRTarBase 
(http://mirtarbase.mbc.nctu.edu.tw/index.php), a database of experimentally validated miRNA-
target interactions that are classified as strong evidence based if there is sufficient published 
empirical evidence.  
Blastocyst gene expression  
/ŶĚŝǀŝĚƵĂůďůĂƐƚŽĐǇƐƚƐƐƚŽƌĞĚŝŶ  ? ?ʅ>ŽĨĞǆƚƌĂĐƚŝŽŶďƵĨĨĞƌ  ?WŝĐŽWƵƌĞ RNA Isolation Kit, Thermo 
Fisher) were incubated at 42°C for 30 min prior to isolating RNA. This procedure entailed adding 
1 volume of 70% EtOH to each sample before transferring to a pre-conditioned purification 
column. Samples were then DNase-treated using the RNase-Free DNase Set (Qiagen) and eluted 
ŝŶ ? ?ʅ>ĨŽůůŽǁŝŶŐƐĞǀĞƌĂůǁĂƐŚĞƐ ?ůů ? ?ʅ>ŽĨƉƵƌŝĨŝĞĚƚŽƚĂůZEǁĂƐƌĞǀĞƌƐĞ-transcribed using 
the High-ĂƉĂĐŝƚǇĐEZĞǀĞƌƐĞ dƌĂŶƐĐƌŝƉƚŝŽŶ<ŝƚ  ?dŚĞƌŵŽ&ŝƐŚĞƌ ? ŝŶĂ ĨŝŶĂů ǀŽůƵŵĞ ŽĨ  ? ?ʅ> ?
The reaction occurred in a thermal cycler at 25°C for 10 min followed by 37°C for 2 h. cDNA 
samples were diluted 1:5 with nuclease-ĨƌĞĞǁĂƚĞƌĂŶĚĂ ?ʅ>ƚĞŵƉůĂƚĞǁĂƐƵƐĞĚĨŽƌƌĞĂů-time 
WZ ƵƐŝŶŐ ƚŚĞ WŽǁĞƌ ^zZ 'ƌĞĞŶ WZ DĂƐƚĞƌ Dŝǆ  ?dŚĞƌŵŽ &ŝƐŚĞƌ ? ĂŶĚ Ă  ? ʅD ƉƌŝŵĞƌ ŵŝǆ
(forǁĂƌĚA?ƌĞǀĞƌƐĞ ?ŝŶĂ ? ?ʅ>ĨŝŶĂůǀŽůƵŵĞ ?ƵƉůŝĐĂƚĞƐŽĨĞĂĐŚƐĂŵƉůĞǁĞƌĞƉĞƌĨŽƌŵĞĚŽŶƚŚĞ
ABI 7300 Real-Time PCR System under the following thermal cycling conditions: 95°C for 10 
min, 40 cycles at 95°C for 15 s and 60°C for 1 min, followed by a dissociation stage to determine 
melt temperatures. Standard curves were also employed for each gene using Universal Human 
Reference RNA (Agilent) in 10-fold serial dilutions and an internal housekeeping gene (PPIA) 
was used to normalize each sample.  
Endometrial cell molecular analysis  
 ƐĂŵƉůĞƐ ǁĞƌĞ ůǇƐĞĚ ŝŶ  ? ? ʅ> ŽĨ ůǇƐŝƐ ƐŽůƵƚŝŽŶ ĂŶĚ ŵŝZEƐ ǁĞƌĞ ŝƐŽůĂƚĞĚ ƵƐŝŶŐ ƚŚĞ
RNaqueous-Micro Kit (Thermo Fisher) which required the addition of 1.25 volumes of 100% 
EtOH prior to loading onto a micro filter cartridge assembly. Samples were DNase-treated in the 
ƐĂŵĞŵĂŶŶĞƌĂƐƚŚĞďůĂƐƚŽĐǇƐƚƐĂŵƉůĞƐ ?ĂŶĚǁĂƐŚĞĚƐĞǀĞƌĂů ƚŝŵĞƐďĞĨŽƌĞĞůƵƚŝŶŐ ŝŶ  ? ?ʅ>ŽĨ
ĞůƵƚŝŽŶƐŽůƵƚŝŽŶƉƌĞǀŝŽƵƐůǇŚĞĂƚĞĚƚŽ ? ? ? ?ƉĞƌĨŽƌŵĞĚƚǁŝĐĞĨŽƌŵĂǆŝŵƵŵƌĞĐŽǀĞƌǇ ? ? ?ʅ>ĨŝŶĂů
volume). miRNA samples were then concĞŶƚƌĂƚĞĚ ĚŽǁŶ ƚŽ Ă  ? ? ʅ> ǀŽůƵŵĞ ƵƐŝŶŐ Ă ǀĂĐƵƵŵ
concentrator (Vacufuge Plus, Eppendorf).  
miRNA samples were pre-amplified, diluted and evaluated using the Taqman Human 
MicroRNA Array Card A (Thermo Fisher) as described in the earlier supernatant exosome 
miRNA analysis section. Data were analyzed using the RQ Manager 1.2.1 (Thermo Fisher) and 
statistical analysis was performed as described in the following.  
Statistical analysis  
A Mann ?Whitney U test was used to compare differences in the age of the donor 
women (fertile control, AMA and endometriosis blastocysts), with significance at P A?0.05. The 
PCR reaction efficiencies recorded R
2 
values A?0.9 and correlation coefficients were calculated to 
be >0.99. Statistical analysis was performed with REST-2009 software (Qiagen) which uses 
bootstrap randomization techniques to correct for exact PCR efficiencies with mean crossing 
point deviations between sample and control groups to determine an expression ratio that is 
tested for significance by a pair wise fixed reallocation randomization test. The standard error 
and the 95% confidence interval (CI) given by REST-2009 software are not derived from Ct 
values. They are the standard error and the CI for the 50,000 iterations the program runs to 
calculate the P value; thus, no error bars are generated for graphical presentation. Gene 
expression fold differences with P A?0.05 were considered statistically significant.  
Results  
Co-culture of AMA blastocysts and fertile control blastocysts  
The age of the donors in the fertile control blastocyst group were significantly different 
than those in the AMA blastocyst group (P A?0.05). Isolated cargo of extracellular vesicles from 
supernatant collected after co-culture of fertile endometrial epithelial cells with blastocysts 
from infertile AMA patients revealed altered miRNA expression profiles compared to fertile 
control blastocysts. A total of 16 miRNAs showed increased expression and 2 exhibited reduced 
expression in association with the maternal age of the blastocyst relative to the internal 
housekeeping gene RNU48 (P A?0.05, Fig. 2). Target gene investigation of these 18 altered 
miRNAs using miRTarBase (http://mirtarbase. mbc.nctu.edu.tw/index.php) revealed 576 genes, 
206 of which displayed strong evidence as defined by Western blot, qPCR or reporter assay as 
described previously. Of these strong evidence-based genes, VEGFA was identified as a target 
gene, specifically regulated by four of the altered miRNAs: miR-126, 150, 29a and 29b. 
Examination of VEGFA transcription by qPCR observed decreased expression in both the 
corresponding endometrial epithelial cells and blastocysts from infertile AMA patients following 





Figure 2 Differential expression of extracellular vesicle-bound miRNAs in co-culture supernatant in association with maternal 
age (*P A䜀 0.05). 
 
 
Figure 3 Target gene VEGFA expression in endometrial cells (A) and AMA blastocysts (B) compared to young fertile controls (*P 
A䜀 0.05). 
Co-culture of endometriosis blastocysts or fertile control blastocysts on donor endometrium or 
endometriosis endometrium  
The ages of the donors in the fertile control blastocyst group were not significantly 
different from those in the endometriosis blastocyst group (P A?0.05; ns). Isolated extracellular 
vesicles from supernatant collected after co-culture of endometriosis EEC with blastocysts from 
endometriosis patients revealed an altered miRNAome compared to fertile controls. 
Specifically, 10 miRNAs showed significant decreased expression including miR-7b miR-24, miR-
34b, miR-200c, miR- 342-3p, miR-9, miR-484, miR-200b, miR-106a and miR-191 (P A?0.05; Figs 4 
and 5) compared to fertile control endometrium co-cultured with fertile control blastocysts. 
Using mirTarBase, strong evidence-based target genes were revealed, including, among others, 
27 target genes for miR-106a. Of these 27 target genes CDKN1A, E2F1 and RUNX1 were chosen 
for further investigation because of their known roles in association with implantation in 
murine (Cdkn1a) (Das 2009) and human models (E2F1 and RUNX1) (Tapia et al. 2011, Tapia-
Pizarro et al. 2014). qPCR analysis observed increased expression of CDKN1A in endometriosis 
blastocysts compared to fertile controls when co-cultured with fertile control derived EEC (P A?
0.05). This expression was further increased when endometriosis derived blastocysts were co-
cultured with endometriosis derived EEC (P A?0.05; Fig. 6A). Endometriosis EEC co-cultured with 
fertile control blastocysts displayed increased expression of E2F1 and RUNX1 (P A?0.05). This 
significant difference in expression was further increased when endometriosis derived 
blastocysts were co-cultured using endometriosis derived EEC(P A?0.05; Fig. 6B).  
Gene ontology and pathway analysis  
DAVID Bioinformatics Resources 6.8 (https://david. ncifcrf.gov/) was utilized for 
functional annotation clustering analyses of differentially expressed miRNAs to explore the GO 
biological processes and pathways, common to both infertility etiologies, and included cellular 
development, proliferation and cell cycle regulation.  
The enriched pathways and processes that were identified as being specific to only the AMA 
etiology included PI3K-Akt and vascular endothelial growth factor (VEGF) signaling, as well as 
biological processes involving cellular development and migration, adhesion and cell cycle 
regulation (P A?0.05; Supplementary Table 1, see section on supplementary data given at the 
end of this article).  
For the endometriosis etiology group, enriched biological processes and pathways crucial for 
development and implantation were revealed within functional annotation clusters of the 1014 
strong evidence-based target genes, including positive regulation of cell proliferation, G1/S 
transition of mitotic cell cycle and the p53 signaling pathway and angiogenesis (P A?0.05). 
Additionally, cell cycle regulation and arrest, positive regulation of cell proliferation, negative 
regulation of apoptotic processes and negative regulation of G1/S transition of mitotic cell 
cycles were also identified (Supplementary Table 2). 
 Figure 4 Experimental groups (CD = fertile control endometrium/fertile control blastocyst; ED = endometriosis 
endometrium/fertile control blastocyst; EE = endometriosis endometrium/endometriosis blastocyst) and the affected miRNAs 
for embryos and endometrial cells derived from patients diagnosed with endometriosis compared with fertile control. 
 
 
Figure 5 Extracellular vesicle-bound microRNA expression of co-culture supernatant. Endometriosis derived blastocysts cultured 
on a monolayer of endometriosis derived endometrial tissue and fertile control derived endometrial tissue, fertile control 
oocyte derived blastocysts (*P A䜀 0.05). 
 Figure 6 (A) miR-106a target gene validation of endometriosis derived blastocysts revealed significantly increased expression of 
CDKN1A when co-cultured with endometriosis derived endometrial cells compared to fertile control (CD = fertile control 
endometrium/ fertile control blastocyst; ED = endometriosis endometrium/fertile control blastocyst; EE = endometriosis 
endometrium/endometriosis blastocyst) (*P A䜀 0.05). (B) miR-106a target gene validation of endometriosis derived endometrial 
cells co-cultured with endometriosis derived blastocysts revealed significantly increased expression of E2F1 and RUNX1 
compared to fertile control derived controls (CD = fertile control endometrium/fertile control blastocyst; ED = endometriosis 
endometrium/fertile control blastocyst; EE = endometriosis endometrium/endometriosis blastocyst) (*P A䜀 0.05). 
 
Discussion  
This is a novel study investigating the bi-directional molecular communication at the 
time of implantation in association with infertility etiologies. Blastocysts from patients 
presenting with AMA or endometriosis were co-cultured on a monolayer of endometrial cells to 
capture the molecular dialogue between a blastocyst and the endometrium during the initial 
stages of implantation. Specific extracellular vesicle-bound miRNAs derived from co-culture 
supernatant were identified to have significantly altered expression in association with AMA or 
endometriosis, highlighted by the differences within embryo-endometrial communication 
depending on the source of the embryo or endometrium. This impacted downstream target 
gene expression in either blastocysts or endometrial cells during the window of implantation.  
Advanced maternal age  
It is well documented that infertile women presenting with advanced maternal age have 
some of the poorest prognoses with regard to oocyte and blastocyst quality. Additionally, there 
is some evidence that the endometrium is also affected by advanced age, resulting in embryo-
endometrial asynchrony (Shapiro et al. 2016). The molecular dialogue between the embryo and 
endometrium is crucial for successful implantation, and it is believed that miRNA-bound 
extracellular vesicles are involved in this bi-directional molecular communication.  
A total of 18 extracellular vesicle-bound miRNAs displayed altered expression with the 
presence of AMA blastocysts. One example was miR-150, a critically important miRNA for 
lineage cell differentiation, which also plays a role in mediating an appropriate inflammatory 
response within the endometrial environment. This response includes not only the endometrial 
epithelial cells and stromal cells, but also the immune-related cells and vasculature (Pan & 
Chegini 2008, Elton et al. 2013, Goossens et al. 2013). Pregnancy is a pro-inflammatory state 
and molecular miscommunication may result in an improperly coordinated auto-immune 
response, leading to inflammation at the implantation site, causing implantation failure and 
embryonic death. This is a delicate balance, and if the immune response is too great or 
insufficient, implantation potential may be impacted (Clark 2008). miR-150 is also a regulatory 
miRNA for the platelet-derived growth factor/VEGF family of genes, responsible for both 
angiogenesis and vasculogenesis, and is vital for successful embryo implantation. It has also 
been shown that supplementing embryo culture media with VEFG had beneficial effects with 
regard to post-compaction mouse embryo development, outgrowth, implantation and fetal 
development (Binder et al. 2014, 2016).  
VEGFA is a glycosylated mitogen that specifically acts on endothelial cells with various effects, 
including mediating vascular permeability, angiogenesis, cell growth and cell migration and 
inhibiting apoptosis. Treatment of human endometrial cells with recombinant human VEGFA 
protein has been found to significantly increase endometrial cell adhesion (Hannan et al. 2011). 
In this study, VEGFA displayed a significantly lower expression in AMA samples (P A?0.05), which 
may lead to dysregulated cellular function and increased apoptosis. This decrease in VEGFA 
expression may be indicative of the compromised communication between the AMA blastocyst 
and fertile control endometrium.  
An additional altered miRNA observed in extracellular vesicles following co-culture was miR- 
135a with an 8-fold decrease in expression in AMA blastocysts (P A?0.05). A previous study 
observed that increased expression of miR-135a during pre-implantation embryo development 
led to the down-regulation of E3 ubiquitin ligase seven in absentia homologue 1A (SIAH1A) 
expression (Pang et al. 2011). The SIAH1A protein is involved in many cellular processes 
including apoptosis, TNF-alpha signaling and cell cycle regulation (Relaix et al. 2000). Nearly a 
third of the zygotes injected with miR-135a inhibitor were observed to arrest in development. 
The mechanism for this disruption is believed to be due to dysregulated proteosomal 
degradation, possibly controlling the expression of chemokines in DNA-binding protein (Pang et 
al. 2011). miR-135a has also been correlated to increased apoptosis resistance in cancer cells by 
BCL2 regulation, a protein which determines cell survival and death through the mitochondrial 
apoptotic signaling pathway. Dysregulation of BCL2 and disruption of the apoptotic pathway 
resulted in interference of not only the establishment of pregnancy, but also pregnancy 
maintenance if successful implantation was able to occur at all (Mathew et al. 2009, Pan et al. 
2014). The dysregulation of miR-135a observed in our samples suggests a decline in the cellular 
regulation of blastocysts derived from AMA patients, thus decreasing their viability and 
implantation potential.  
Another miRNA found in the extracellular vesicles of the supernatant that displayed 
significantly disrupted differential expression was miR-449b. One strong, evidence-based target 
gene for miR-449b is NOTCH1 which has demonstrated its ability to act as a promoter of 
centriole multiplication multiciliogenesis by repressing the Delta/Notch pathway in Xenopus 
laevis embryonic dermis (Marcet et al. 2011). It is currently unknown precisely how mammalian 
cells are affected by this pathway; however it is hypothesized that, rather than the cilia found in 
Xenopus cells, it is the formation of the pseudopodia within the blastocyst trophectoderm that 
is being directly regulated (Goossens et al. 2013). miR-449b showed significantly increased 
expression in the co-culture supernatant of AMA blastocysts, which may indicate compromised 
trophectoderm formation, leading to an increase in failed implantation as observed clinically in 
this patient population.  
Endometriosis  
Endometriosis is a disease characterized by an abnormal, and in many cases, compromised 
endometrium. The impact this diagnosis bears on the bi-directional embryo-endometrial 
dialogue at the time of implantation is largely unexplored. In our study, co-culture of 
endometriosis endometrium with blastocysts derived from patients diagnosed with 
endometriosis displayed significantly decreased extracellular miRNA, from within the isolated 
extracellular vesicles, when compared to fertile control endometrium with fertile control 
derived blastocysts for 10 key miRNAs (P A?0.05). Of particular interest was miR-106a, 
commonly associated with adherens junctions, receptor interactions, metabolic pathways and 
VEGF signaling. In one study utilizing a uterine cavity lavage, miR-106a was identified in the 
exosomes found within the mucus near the time implantation may occur. It is suspected that as 
the blastocyst transitions toward the implantation site and begins to adhere, exosomes trapped 
within the mucus on the luminal surface of the endometrium release miRNAs which contribute 
to endometrial-embryo crosstalk by binding to the trophectoderm cells themselves (Ng et al. 
2013). miR-106a has also revealed itself to be a strong identifying biomarker for various types 
of cancer where it is often down-regulated (Wang 2016). MiRTarBase target gene analysis of 
miR-106a identified 29 strong evidence-based target genes, including CDKN1A, E2F1 and 
RUNX1.  
CDKN1A works in conjunction with TP53 and is linked to stress response in the G1 phase. If 
this stress response continues to cascade, it causes arrested cell cycle, potentially 
compromising the viability of embryos, and also contributing to possible de-regulation of the 
endometrium itself (Sharma et al. 2016). CDKN1A expression has been shown to induce cellular 
growth, arrest, terminal differentiation or apoptosis (Ying et al. 2011). Altered aberrant 
CDKN1A expression is also believed to play a vital role in the pathogenesis of specific cancer 
types, including ovarian and uterine carcinomas (Elbendary et al. 1996). Our results 
demonstrate altered CDKN1A gene expression in blastocysts derived from patients diagnosed 
with endometriosis, which may negatively impact their viability, and also contribute to the 
reduced implantation potential of embryos derived from this patient population. 
E2F1 is a transcription factor that plays a crucial role in the control of the cell cycle and can 
mediate apoptosis. Over-expression of E2F1 in myoblasts has demonstrated proliferation 
stimulation while also inhibiting differentiation (Luo et al. 2016). E2F1 induces the transcription 
of several genes involved in cell cycle entry, resulting in either the induction or inhibition of 
apoptosis. This influence leads to both negative and positive feedback loops, having a critical 
ŝŵƉĂĐƚŽŶƚŚĞŽƵƚĐŽŵĞŽĨƚŚĞĐĞůů ?ƐĨĂte. The E2F1 protein has also shown increased expression 
in patients diagnosed with endometrial cancer, where the cell cycle becomes accelerated and 
irregular (Mints et al. 2016). Decreased expression of miR-106a can increase p53 expression in 
human glioma cells by inhibiting E2F1, negatively effecting cell proliferation and inducing 
apoptosis (Yang et al. 2011, Feng et al. 2013). Within the endometrium derived from patients 
diagnosed with endometriosis, irregular feedback loops may lead to inhibited differentiation, 
compromising the viability of the implantation site.  
RUNX1 is also a transcription factor that, when over expressed, increases apoptosis. In a 
mouse embryo knockout study, embryos with homozygous mutations on Runx1 terminated 
after 12.5 days of development, and suffered from a lack of fetal liver hematopoiesis as well as 
hemorrhaging of the central nervous system (Okuda et al. 1996, Wang et al. 1996). Similar to 
E2F1, over-expression of the RUNX1 protein has been linked to various forms of cancer, 
including endometrial and endometrioid carcinomas (Planaguma et al. 2004, Abal et al. 2006). 
In mice, Runx1 also plays an important role in regulating the gene expression of Ada in 
trophoblast cell lineage which is critical for embryo development (Schaubach et al. 2006). In our 
study, endometriosis derived endometrium showed increased expression of RUNX1 that may 
lead to decreased implantation potential by compromising hematopoiesis and influencing the 
gene expression of placental ADA.  
DAVID functional annotation bioinformatics microarray analysis revealed further dysfunction 
within the expression of miRNAs for both infertility etiologies, in relation to GO biological 
processes and pathways. When comparing the three different design groups, we found that 
miR-24, 34b and 484 were not commonly expressed between the groups of ED vs CD and EE vs 
CD, highlighting a subset of developmental pathways that were affected by the presence of 
endometrial cells from patients diagnosed with endometriosis (Supplementary Table 3). 
Interestingly, there were also no significant differences in miRNA expression between the 
groups of EE and ED (P > 0.05), which may signify that the endometriosis EEC are contributing 
the majority of the extracellular vesicles to the supernatant and may impact the developmental 
potential of the implanting blastocyst. One commonality between the endometriosis and AMA 
groups was the focus on cell cycle regulation. This may be indicative of compromised dialogue 
within the extracellular matrix. As the window of implantation approaches, specific auto-
induction loops must occur to mediate the critical crosstalk between a competent blastocyst 
and the uterine epithelium at the implantation site (Hamatani et al. 2004). If these critical 
processes and pathways are disrupted, the resulting cell cycle dysregulation may contribute to 
a harsh environment, unsuitable for implantation and further development necessary for a 
viable pregnancy by preventing firm adhesion between the blastocyst and the uterine 
epithelium (Wang et al. 2008).  
A few limitations of this study include the source of the endometrial biopsy. These biopsies 
were taken at the time of oocyte retrieval from women undergoing controlled ovarian 
stimulation. It has been shown that this leads to estrogen-dependent changes in the protein 
profiles of the endometrial compartments which may affect endometrial receptivity (Ullah et al. 
2017). Furthermore, due to the scarcity of research materials, these protein profile alterations 
were unable to be validated further by ELISA analysis.  
In conclusion, our study displayed a theme of compromised cellular communication in 
blastocysts and endometrium derived from patients diagnosed with AMA or endometriosis. 
These alterations may account for the lower implantation potential and clinical outcomes 
observed for these infertile patient populations. Any compromise in the delicate embryo-
endometrial molecular dialogue, either autocrine or paracrine, may impact transcription levels 
of key miRNAs and their target signaling molecules, resulting in significantly lower potential for 
reproductive success. Further investigation of the bi-directional molecular dialogue may help 
elucidate important implantation biomarkers during this critical time point, and advance our 
understanding of reproductive success.  
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Supplementary Table I:  Enriched pathways of statistically significant miRNA target genes 
(p<0.05) increased or decreased in the Endometriosis group compared to donor controls 
hsa-miR-106a 
   GO Term Term # of genes P-Value 
GO:0008284 positive regulation of cell proliferation 4 3.40E-02 
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle 3 6.80E-04 
GO:0043066 negative regulation of apoptotic process 7 5.60E-05 
GO:0051726 regulation of cell cycle 5 3.70E-05 




hsa04110 Cell cycle 5 3.10E-04 
    hsa-miR-let-7b 
   GO Term Term # of genes P-Value 
GO:2000766 negative regulation of cytoplasmic translation 3 8.30E-05 
GO:0071230 cellular response to amino acid stimulus 4 1.16E-04 
GO:0000082 G1/S transition of mitotic cell cycle 5 5.17E-05 
GO:0051301 cell division 7 6.45E-05 
GO:0001934 positive regulation of protein phosphorylation 3 0.027192 
GO:0030335 positive regulation of cell migration 6 3.22E-05 
GO:0008284 positive regulation of cell proliferation 5 0.014057 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04914 Progesterone-mediated oocyte maturation 7 3.76E-07 
hsa04152 AMPK signaling pathway 6 5.13E-05 
hsa04914 Progesterone-mediated oocyte maturation 7 3.76E-07 
hsa04114 Oocyte meiosis 4 0.006072 
hsa04110 Cell cycle 5 7.95E-04 
hsa04115 p53 signaling pathway 3 0.022282 
hsa04151 PI3K-Akt signaling pathway 10 1.17E-06 
hsa04068 FoxO signaling pathway 7 4.80E-06 
hsa05213 Endometrial cancer 3 0.013792 
    hsa-miR-200c 
   
GO Term Term # of genes P-Value 
GO:0001525 angiogenesis 7 6.36E-04 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 6 2.22E-05 
GO:0010595 positive regulation of endothelial cell migration 4 0.001315 
GO:0001701 in utero embryonic development 7 2.49E-04 
GO:0035924 
cellular response to vascular endothelial growth factor 
stimulus 4 1.66E-04 
GO:0045766 positive regulation of angiogenesis 5 0.002113 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04510 Focal adhesion 9 6.30E-05 
 
Supplementary Table II:  Enriched pathways of statistically significant miRNA target 
genes (p<0.05) increased or decreased in the AMA group 
hsa-miR-126 
   
GO Term Term 
# of 
genes P-Value 
GO:0001938 positive regulation of endothelial cell proliferation 5 3.13E-05 
GO:0045766 positive regulation of angiogenesis 5 2.29E-04 
GO:0001525 angiogenesis 5 2.70E-03 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 3 1.53E-02 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04151 PI3K-Akt signaling pathway 10 1.32E-05 
hsa04012 ErbB signaling pathway 6 3.70E-05 
hsa04015 Rap1 signaling pathway 7 2.86E-04 
hsa04370 VEGF signaling pathway 4 2.46E-03 
hsa04210 Apoptosis 4 2.59E-03 
hsa04668 TNF signaling pathway 4 1.15E-02 
hsa04010 MAPK signaling pathway 5 2.60E-02 
hsa04664 Fc epsilon RI signaling pathway 3 3.69E-02 
hsa05213 Endometrial cancer 5 7.72E-05 
hsa04152 AMPK signaling pathway 5 2.01E-03 
    miR-150 
   
GO Term Term 
# of 
genes P-Value 
GO:0043066 negative regulation of apoptotic process 5 3.68E-03 
GO:0008284 positive regulation of cell proliferation 5 4.00E-03 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04110 Cell cycle 3 4.90E-02 
    miR-29a 
   
GO Term Term 
# of 
genes P-Value 
GO:2000352 negative regulation of endothelial cell apoptotic process 4 2.80E-04 
GO:0007160 cell-matrix adhesion 5 7.75E-04 
GO:0030335 positive regulation of cell migration 9 1.97E-06 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 3 4.32E-02 
    
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04510 Focal adhesion 16 1.81E-11 
hsa04151 PI3K-Akt signaling pathway 18 3.14E-10 
hsa04068 FoxO signaling pathway 7 5.17E-04 
hsa04115 p53 signaling pathway 5 1.65E-03 
hsa05213 Endometrial cancer 4 7.22E-03 
hsa04370 VEGF signaling pathway 4 1.12E-02 
    miR-29b 
   
GO Term Term 
# of 
genes P-Value 
GO:0030335 positive regulation of cell migration 11 8.74E-09 
GO:0051781 positive regulation of cell division 7 6.01E-08 
GO:0043406 positive regulation of MAP kinase activity 7 2.42E-07 
GO:0016477 cell migration 6 1.03E-03 
GO:0050680 negative regulation of epithelial cell proliferation 4 2.00E-02 
GO:0016049 cell growth 4 2.00E-02 
GO:0043065 positive regulation of apoptotic process 7 2.22E-02 
GO:0007050 cell cycle arrest 4 2.52E-02 
GO:0007160 cell-matrix adhesion 8 1.48E-07 
GO:0050714 positive regulation of protein secretion 6 5.25E-07 
GO:2000352 negative regulation of endothelial cell apoptotic process 5 6.93E-06 
GO:0048010 vascular endothelial growth factor receptor signaling pathway 3 4.11E-02 




hsa04510 Focal adhesion 22 2.71E-19 
hsa04151 PI3K-Akt signaling pathway 24 4.96E-17 
hsa04014 Ras signaling pathway 9 2.51E-04 
hsa04068 FoxO signaling pathway 7 4.65E-04 
hsa05213 Endometrial cancer 4 6.85E-03 
hsa04110 Cell cycle 6 2.27E-03 
hsa04350 TGF-beta signaling pathway 5 3.53E-03 
hsa04370 VEGF signaling pathway 4 1.06E-02 
hsa04390 Hippo signaling pathway 5 2.64E-02 
hsa05213 Endometrial cancer 4 6.85E-03 
hsa04370 VEGF signaling pathway 4 1.06E-02 
hsa04668 TNF signaling pathway 4 4.51E-02 
 
Supplementary Table III:  Enriched pathways of statistically significant miRNA target 
genes (p<0.05) increased or decreased in Combined Differentially expressed miRNA in 
Association with Endometriosis Diagnosis Endometrial Cells 
GO Term Term 
# of 
genes P-Value 
GO:0000082 G1/S transition of mitotic cell cycle 12 4.01E-12 
GO:0051301 cell division 8 0.002112036 
GO:0001701 in utero embryonic development 7 3.96E-04 
GO:0060070 canonical Wnt signaling pathway 4 0.00887545 
GO:0016055 Wnt signaling pathway 4 0.071185563 
GO:0048599 oocyte development 3 0.001949408 
GO:2001234 negative regulation of apoptotic signaling pathway 3 0.002969315 
GO:0045766 positive regulation of angiogenesis 6 3.09E-04 
GO:0001525 angiogenesis 6 0.005756441 
 
KEGG Pathway Pathway 
# of 
Genes P-Value 
hsa04151 PI3K-Akt signaling pathway 16 3.01E-07 
hsa04110 Cell cycle 13 8.02E-10 
hsa04115 p53 signaling pathway 7 2.92E-05 
hsa04390 Hippo signaling pathway 8 4.11E-04 
hsa05213 Endometrial cancer 5 0.001224143 
hsa04310 Wnt signaling pathway 6 0.008213403 
hsa04510 Focal adhesion 9 5.15E-04 
hsa04370 VEGF signaling pathway 4 0.017862483 
hsa04350 TGF-beta signaling pathway 5 0.007023653 
hsa04068 FoxO signaling pathway 5 0.033410186 
hsa04010 MAPK signaling pathway 6 0.081996404 
 
 
